An ongoing project for me and many of you I am sure as more information emerges. I am no medical reimbursement expert. It doesn't help that we have no reliable market pricing for Striate/Remplir - that no one on here can get a professional dentistry/maxillofacial friend to look up BioHorizons prices is a bit disappointing.
DVT's product website doesn't even have Remplir listed. Clearly the 682 sales come from existing sales routes and simply supplied by DVT. Another example of disappointing business tardiness, but that they achieved such raped growth in Remplir sales without the product even being formally listed on DVT's online catalogue, says the revenue potential for Australia and Remplir has barely been scratched.
This is very simplified, but for those who didn't work it out, if you took the Appendix 4C's units sales figures as verbatim and the accrued revenues, taking a $1,354 revenue price for Remplir (per the reimbursement schedule) it would give you around $93 average revenue on Striate:
($1,354 x 682 Remplir) + ($93 x 10936 Striate) = $194K
Obviously no way that simple. But it gives investors on here an idea. Taking a more conservative actual average revenue on Remplir units to OCC might give you something like:
($1,000 x 682 Remplir) + ($115 x 10936 Striate) = $194K
For those who don't recall OCC reported very rapid overall, but variable by quarter, sales increases in their Appendix 4C for this year:
FY23 1 Qtr Sriate Remplir 2 4 5482 362 3 3 2339 100 4 2 2726 36 5 1 389 184 6 7 FY23 10936 682
- Forums
- ASX - By Stock
- OCC
- Ann: Appendix 4E & Annual Report
Ann: Appendix 4E & Annual Report, page-13
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $76.49M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 36.5¢ | $9.932K | 27.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29838 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 5465 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27099 | 0.365 |
6 | 113240 | 0.360 |
5 | 59319 | 0.355 |
7 | 91882 | 0.350 |
2 | 31889 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 5465 | 2 |
0.380 | 19190 | 2 |
0.390 | 29373 | 5 |
0.395 | 30226 | 2 |
0.400 | 71786 | 4 |
Last trade - 14.41pm 23/08/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online